Literature DB >> 8875348

Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.

S B Hansel1, M E Morris.   

Abstract

Conjugation/deconjugation cycling plays an important role in the physiologic regulation of the concentration of endogenous compounds that form conjugated metabolites. Less is known concerning the deconjugation of xenobiotics. The model compound p-nitrophenol (pNP) is conjugated to sulfate and glucuronide metabolites which can also undergo hydrolysis, via separate enzyme systems, to regenerate pNP. In the present investigation, computer simulations were performed using literature values for the KM and Vmax for each of the four enzyme systems involved in net pNP conjugation. The apparent sulfation rate, apparent glucuronidation rate, and the extraction ratio (E) of pNP were each examined (i) as a function of pNP concentration, (ii) following alterations in the KM and Vmax values for the deconjugation enzymes, (iii) after modulating the enzyme distribution patterns along the liver flow path for both the conjugating and deconjugating enzymes, and (iv) in the presence of drug metabolite diffusional barriers for membrane transport. Results of these simulations demonstrated that changes in the KM or Vmax for deglucuronidation produced changes not only in net glucuronidation but also in net sulfation. Overall extraction (E) of the parent compound was only affected when glucuronidation was an important pathway, i.e., at higher pNP concentrations. Similar results were observed with changes in desulfation, with desulfation having the greatest effects at low pNP concentrations where sulfation represents the predominant metabolic pathway. Changes in the enzyme distribution patterns for the deconjugation pathways showed that the greatest influence on net conjugation rates occurred when hydrolase enzyme activity was distributed downstream from the respective forward reaction. In the presence of a diffusional barrier for metabolite transport (i.e., when the diffusional clearance was one tenth of blood flow), net metabolism of parent was diminished with E decreasing from 0.74, in the absence of a barrier, to 0.23, since the generated metabolite remained, to a great extent, within hepatocytes and underwent a more pronounced hydrolysis. In the presence of diffusional barriers for uptake of the conjugated metabolites, the lowest drug extraction and metabolite formation rates were observed when the distribution of the conjugation and deconjugation pathways across the liver were the same. Therefore, the effects of deconjugation on hepatic drug removal and metabolite formation are highly dependent on the enzymatic parameters of both the forward and reverse reactions, the parent drug concentration, the enzyme distribution patterns, and the presence of diffusional barriers for metabolite membrane transport. Since a change in the deconjugation of one metabolite can influence the net formation of not only itself but also other metabolites, and overall drug extraction, evaluation of conjugation/deconjugation cycling represents an important consideration in pharmacokinetic studies involving physiological-, pathological-, or pharmacological-induced alterations in conjugate formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875348     DOI: 10.1007/bf02353490

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  30 in total

1.  Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver.

Authors:  M el Mouelhi; F C Kauffman
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

2.  Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in "enzyme-distributed" models: a computer-aided simulation study.

Authors:  S Miyauchi; Y Sugiyama; H Sato; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

3.  Effect of diffusional barriers on drug and metabolite kinetics.

Authors:  I A de Lannoy; K S Pang
Journal:  Drug Metab Dispos       Date:  1987 Jan-Feb       Impact factor: 3.922

Review 4.  The clinical aspects of arylsulphatases.

Authors:  A A Farooqui; P Mandel
Journal:  Clin Chim Acta       Date:  1977-01-17       Impact factor: 3.786

5.  Futile cycling of a sulfate conjugate by isolated hepatocytes.

Authors:  F C Kauffman; M Whittaker; I Anundi; R G Thurman
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

6.  Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.

Authors:  S Ratna; M Chiba; L Bandyopadhyay; K S Pang
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

7.  Stimulation of 3-benzo[a]pyrenyl glucuronide hydrolysis by calcium activation of microsomal beta-glucuronidase.

Authors:  M Whittaker; P M Sokolove; R G Thurman; F C Kauffman
Journal:  Cancer Lett       Date:  1985-03       Impact factor: 8.679

8.  Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal beta-glucuronidase activity.

Authors:  F M Brunelle; R K Verbeeck
Journal:  Biochem Pharmacol       Date:  1993-12-03       Impact factor: 5.858

9.  Calcium-mediated inhibition of glucuronide production by epinephrine in the perfused rat liver.

Authors:  S A Belinsky; F C Kauffman; P M Sokolove; T Tsukuda; R G Thurman
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  The conjugative metabolism of 4-methylumbelliferone and deconjugation to the parent drug examined by isolated perfused liver and in vitro liver homogenate of rats.

Authors:  S Miyauchi; Y Sugiyama; T Iga; M Hanano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-02       Impact factor: 1.645

View more
  2 in total

Review 1.  Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.

Authors:  K Sandy Pang; Matthew R Durk
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-14       Impact factor: 2.745

Review 2.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.